Back to News
Market Impact: 0.35

European markets set to open flat to lower in struggle to find momentum

Monetary PolicyInterest Rates & YieldsEconomic DataFiscal Policy & BudgetLegal & LitigationRenewable Energy TransitionBanking & LiquidityInvestor Sentiment & Positioning
European markets set to open flat to lower in struggle to find momentum

European equities opened mixed with the Stoxx 600 near flat and utilities leading early gains (Stoxx Europe Utilities +0.4%; Orsted +2.2%, EDP +1%, SSE +0.9%). Markets are positioning for central bank moves ahead of the Dec. 9-10 Fed meeting, with the CME FedWatch Tool pricing an 87.2% chance of a 25bp cut, while the BOE watches for spillovers amid signs of cooling inflation and Autumn Budget disinflationary measures. Corporate headlines included Bayer jumping ~12.5% after the U.S. Solicitor General urged the Supreme Court to limit Roundup litigation, and Santander rising ~1% after selling a 3.5% stake in Santander Polska for about $473m (retaining a 9.7% stake). Data due include Spanish and Italian unemployment and EU inflation figures.

Analysis

Market structure: The near-term winner set is rate-sensitive, high-dividend utilities (e.g., ORSTED.CO, EDP.LS, SSE.L) as markets price a 25bp Fed cut on Dec 9–10 (87.2% priced). Banks and rate-carry lenders are the clear losers as cuts compress NII; Santander (SAN.MC) and broader STOXX Banks are vulnerable if cuts materialize and UK/Euro growth remains tepid. Cross-asset: a Fed cut typically pushes US yields down 10–30bp near-term, supporting European sovereigns and lifting equities and FX (EUR/USD upside risk of ~1–2% around the decision). Risk assessment: Tail risks include an unexpected Fed pause (probability ~15–25%) that would spike 2s/10s yields and punish utilities, and an adverse US Supreme Court ruling against Bayer (BAYN.DE) despite govt briefs, which could reverse the 12% rally — assign ~10–20% event risk over 3–6 months. Time horizons: immediate (days) will see positioning into the Fed and labor/CPI prints, short-term (weeks) will be earnings/portfolio rebalances and legal filings, long-term (quarters) depends on actual rate path and European growth data. Hidden dependencies: UK BOE follow-through and FX-driven earnings translation for exporters are underappreciated; a >1% move in EUR/GBP could swing reported EPS by several percent for multi-nationals. Trade implications: Direct plays: overweight European utilities and long-duration names for 1–3 months, underweight banks for 3–6 months; use 3-month calls on ORSTED and buy puts or short positions in SAN.MC or STOXX Banks. Pair trades: long ORSTED.CO (2–3% portfolio) vs short SAN.MC (1.5–2%); this isolates rate-sensitivity vs NII compression. Options: implement 3-month 25–45 delta call positions on utilities (cost cap 1% portfolio) and 90-day put spreads on banks to limit premium outlay while gaining convexity. Contrarian angles: The market may be underpricing residual legal tail for Bayer despite US government support — the rally could be overdone if the Court narrows preemption; keep exposure minimal (<=1%). Conversely, consensus could be underestimating a BOE cut follow-through that would further help UK utilities and gilts — a BOE cut alongside Fed easing could send GBP lower 1–2% and boost domestic defensives. Historical parallels: 2019 pre-cut rallies favored utilities but reversed if growth disappointed; if growth data weakens materially after the Fed cut, cyclicals can suffer more than current pricing implies. Unintended consequence: rate cuts that lift equities may still leave bank credit spreads wide, amplifying systemic risk in regional lenders over 6–12 months.